Overview

Multimodal Imaging Market is poised to value over CAGR of over 4.3% during the forecast period 2022 to 2028. 

Advancements in diagnostic imaging technology, broadened range of applications in multimodal imaging systems, increased research funding, favourable reimbursement policies, increased research and development in radiotracers and rise in the insurance coverage are the key driving factors of the market. Multimodal imaging is mainly used for drug discovery and in non-invasive and invasive surgical procedures which shall augment the multimodal imaging market growth. The optical fluorescence imaging has garnered a huge demand as it is very efficient in providing real-time images. This imaging method is used extensively for studying molecular events which is why it is often deployed in surgeries that require image guidance. All these factors shall bolster the growth of the market.

Market Segmentation:

By Technology
•    PET-CT
•    SPECT-CT
•    PET-MR
•    OCT
•    Trimodal       
By Application
•    Cardiology
•    Brain and Neurology
•    Ophthalmology
•    Oncology
•    Others    
By End User 
•    Hospitals
•    Diagnostic Imaging Centers
•    Other End Users    
By Region
•    North America
•    Europe
•    Asia-Pacific
•    Latin America
•    Middle East and Africa

The market is classified into technology, application, end user and region. The technology segment is fragmented into PET-CT, SPECT-CT, PET-MR, OCT and Trimodal. The PET-CT systems held the largest multimodal imaging market share owing to the rising insistence for accurate and early diagnosis of cancer, increased clinical evidence for detecting Alzheimer’s disease as early as possible. The application segment is divided into cardiology, brain and neurology, ophthalmology, oncology and other applications. The oncology segment is predicted to dominate the market owing to the rising incidence of cancer across the world, extensive usage of multimodal system for diagnosing tumors. The end user segment is bifurcated into diagnostic imaging centres, hospitals and other end users. The hospital segment subjugated the market owing to increased installations of advanced imaging systems such as SPECT-CT and PET-CT, increased demand for diagnostic processes that are non-invasive in nature. 

Regional Analysis:

The North America region is expected to lead the market owing to the integration of advanced multimodal imaging systems in hospital settings, improves reimbursement scenario, increased financial assistance pertaining to the novel imaging systems. However, the Asia Pacific region is predicted to grow at a substantial rate during the forecast period and this can be credited to improvements in the healthcare infrastructure, increasing patient population and improving insurance coverage policies. 

Competitive Landscape:                            

Some of the prominent market players are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Canon Inc., United Imaging Healthcare Co. Ltd., Mediso Medical Imaging Systems Kft, Neusoft Medical Systems Co. Ltd., Infraredx Inc., Spectrum Dynamics Medical, Topcon Corporation, Heidelberg Engineering, Carl Zeiss AG, Optovue Inc., Nidek Co., Ltd., Optos Plc (UK) (a part of Nikon Corporation), Kowa Company, Ltd.

FutureWise Key Takeaways:

•    Growth prospects
•    SWOT analysis 
•    Key market trends 
•    Key data-points affecting market growth

Objectives of the Study:

•    To provide with an exhaustive analysis on the global multimodal imaging market by technology, by application, by end user and by region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•    To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions   

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com  

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Multimodal Imaging Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Multimodal Imaging Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Multimodal Imaging Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Multimodal Imaging Market, By Technology Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million)
           7.1 PET-CT
           7.2 SPECT-CT
           7.3 PET-MR
           7.4 OCT
           7.5 Trimodal    
                
8. Multimodal Imaging Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million)
           8.1 Cardiology
           8.2 Brain and Neurology
           8.3 Ophthalmology
           8.4 Oncology
           8.5 Others 
         
9. Multimodal Imaging Market, By End User Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million)
            9.1 Hospitals
            9.2 Diagnostic Imaging Centers
            9.3 Other End Users    

10. North America Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1 Koninklijke Philips N.V.
            16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.1.2. Product Portfolio
            16.1.3. SWOT Analysis
            16.1.4. Financial Overview
            16.1.5. Strategic Overview
    16.2 Canon Inc.
             16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.2.2. Product Portfolio
              16.2.3. SWOT Analysis
              16.2.4. Financial Overview
              16.2.5. Strategic Overview
    16.3 United Imaging Healthcare Co. Ltd.
              16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.3.2. Product Portfolio
              16.3.3. SWOT Analysis
              16.3.4. Financial Overview
              16.3.5. Strategic Overview
    16.4 Siemens
            16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.4.2. Product Portfolio
             16.4.3. SWOT Analysis
             16.4.4. Financial Overview
             16.4.5. Strategic Overview
    16.5 Mediso Medical Imaging Systems Kft
              16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.5.2. Product Portfolio
              16.5.3. SWOT Analysis
              16.5.4. Financial Overview
              16.5.5. Strategic Overview
    16.6 Neusoft Medical Systems Co. Ltd.
              16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.6.2. Product Portfolio
              16.6.3. SWOT Analysis
              16.6.4. Financial Overview
              16.6.5. Strategic Overview
    16.7 Infraredx Inc.
             16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.7.2. Product Portfolio
             16.7.3. SWOT Analysis
             16.7.4. Financial Overview
             16.7.5. Strategic Overview
    16.8 Spectrum Dynamics Medical
              16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.8.2. Product Portfolio
              16.8.3. SWOT Analysis
              16.8.4. Financial Overview
              16.8.5. Strategic Overview    
    16.9 Topcon Corporation
              16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.9.2. Product Portfolio
              16.9.3. SWOT Analysis
              16.9.4. Financial Overview
              16.9.5. Strategic Overview
    16.10 GE Healthcare
              16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.10.2. Product Portfolio
              16.10.3. SWOT Analysis
              16.10.4. Financial Overview
              16.10.5. Strategic Overview
    16.11 Heidelberg Engineering
              16.11.1. Company Overview (HQ, Business Segments, Employee Strength)
              16.11.2. Product Portfolio
              16.11.3. SWOT Analysis
              16.11.4. Financial Overview
              16.11.5. Strategic Overview
    16.12 Carl Zeiss AG
             16.12.1. Company Overview (HQ, Business Segments, Employee Strength)
             16.12.2. Product Portfolio
             16.12.3. SWOT Analysis
             16.12.4. Financial Overview
             16.12.5. Strategic Overview
    16.13 Optovue Inc.
            16.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.13.2. Product Portfolio
            16.13.3. SWOT Analysis
            16.13.4. Financial Overview
            16.13.5. Strategic Overview
    16.14 Nidek Co., Ltd.
            16.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.14.2. Product Portfolio
            16.14.3. SWOT Analysis
            16.14.4. Financial Overview
            16.14.5. Strategic Overview
     16.16 Optos Plc (UK) (a part of Nikon Corporation)
            16.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.16.2. Product Portfolio
            16.16.3. SWOT Analysis
            16.16.4. Financial Overview
            16.16.5. Strategic Overview
    16.16 Kowa Company Ltd.
            16.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.16.2. Product Portfolio
            16.16.3. SWOT Analysis
            16.16.4. Financial Overview
            16.16.5. Strategic Overview

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the regulations initiated by healthcare administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client
 

Tables

Figures